Status:
COMPLETED
Sheathotomy vs. Intravitreal Triamcinolone for Branch Retinal Vein Occlusion
Lead Sponsor:
Yonsei University
Conditions:
Macular Edema
Branch Retinal Vein Occlusion
Eligibility:
All Genders
Phase:
NA
Brief Summary
Branch retinal vein occlusion (BRVO) is a common retinal vascular disease occurring in a significant number of individuals older than 50 years.The most common cause of visual disturbance in BRVO patie...
Eligibility Criteria
Inclusion
- recent onset (within the 6 months prior to enrollment) of macular edema resulting from BRVO
- best corrected Early Treatment Diabetic Retinopathy Study (ETDRS) scores ≤ 40 letters (Snellen equivalent ≤ 20/40
- intraretinal hemorrhages involving the foveal centers
- generalized breakdown of the inner blood-retina barrier, as documented by diffuse fluorescein leakage on angiography, or diffuse thickening of the retina on optical coherence tomography (OCT), with involvement of the foveal center and most of the macular area, and with foveal thicknesses ≥ 250 micrometer
Exclusion
- prior history of intraocular surgery including cataract extraction
- prior history of laser treatments including panretinal photocoagulation and focal/grid macular photocoagulation
- prior history of elevated intraocular pressure secondary to steroid treatment
- prior history of glaucoma or ocular hypertension
- presence of comorbid ocular conditions that might affect visual acuity (VA).
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2007
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00612261
Start Date
October 1 2006
End Date
August 1 2007
Last Update
February 11 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yonsei University Health System
Seoul, South Korea, 120-752